ZIVO Bioscience, Inc.
ZIVO
Price:
$20.89
Market Cap:
$74.08M
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscie...[Read more]
Industry
Biotechnology
IPO Date
2003-12-15
Stock Exchange
NASDAQ
Ticker
ZIVO
PE Ratio
[-4.33]
ROE
[618.61%]
Current Ratio
[0.17]
Dividend Yield
[0%]
Enterprise Value
[73.95M]
Dividend History
The ROE as of November 2024 (TTM) for ZIVO Bioscience, Inc. (ZIVO) is 618.61%
According to ZIVO Bioscience, Inc.’s latest financial reports and current stock price. The company's current ROE is 618.61%. This represents a change of 305.27% compared to the average of 152.64% of the last 4 quarters.
ZIVO Bioscience, Inc. (ZIVO) Historical ROE (quarterly & annually)
How has ZIVO ROE performed in the past?
The mean historical ROE of ZIVO Bioscience, Inc. over the last ten years is 8.30%. The current 618.61% ROE has changed -92.55% with respect to the historical average. Over the past ten years (40 quarters), ZIVO's ROE was at its highest in in the December 2022 quarter at 24.86%. The ROE was at its lowest in in the September 2022 quarter at -131.50%.
Average
8.30%
Median
63.63%
Minimum
-155.52%
Maximum
82.33%
ZIVO Bioscience, Inc. (ZIVO) ROE by Quarter and Year
Discovering the peaks and valleys of ZIVO Bioscience, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 167.82%
Maximum Annual ROE = 82.33%
Minimum Annual Increase = -53040.85%
Minimum Annual ROE = -155.52%
| Year | ROE | Change |
|---|---|---|
| 2023 | 352.57% | -99.57% |
| 2022 | 82.33% | -53040.85% |
| 2021 | -155.52% | -282.17% |
| 2020 | 85.37% | -51.47% |
| 2019 | 175.91% | 167.82% |
| 2018 | 65.68% | 6.68% |
| 2017 | 61.57% | 38.40% |
| 2016 | 44.49% | -27.02% |
| 2015 | 60.96% | -670.27% |
| 2014 | -10.69% | -110.16% |
ZIVO Bioscience, Inc. (ZIVO) Average ROE
How has ZIVO ROE performed in the past?
The current ROE of ZIVO Bioscience, Inc. (ZIVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
27.51%
5-year avg
16.56%
10-year avg
8.30%
ZIVO Bioscience, Inc. (ZIVO) ROE vs. Peers
How is ZIVO’s ROE compared to its peers?
ZIVO Bioscience, Inc.’s ROE is greater than RenovoRx, Inc. (-242.57%), greater than Pasithea Therapeutics Corp. (-15595.10%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than ARCA biopharma, Inc. (-20.18%), less than Theseus Pharmaceuticals, Inc. (0%), greater than Erasca, Inc. (-12.35%), greater than Forte Biosciences, Inc. (-42.26%), greater than Applied Molecular Transport Inc. (-151.43%), greater than Senti Biosciences, Inc. (-131.59%), greater than Cadrenal Therapeutics, Inc. Common Stock (-154.84%), greater than Foghorn Therapeutics Inc. (-142.95%), less than Tempest Therapeutics, Inc. (167.93%), greater than Ikena Oncology, Inc. (-187.44%), greater than Catalyst Biosciences, Inc. (-39.59%), greater than null (-107.89%),
| Company | ROE | Market cap |
|---|---|---|
| -242.57% | $30.96M | |
| -15595.10% | $3.93M | |
| -126.19% | $2.95M | |
| -20.18% | $34.82M | |
| 0% | $181.50M | |
| -12.35% | $763.36M | |
| -42.26% | $23.39M | |
| -151.43% | $11.01M | |
| -131.59% | $9.96M | |
| -154.84% | $24.86M | |
| -142.95% | $435.85M | |
| 167.93% | $39.52M | |
| -187.44% | $82.52M | |
| -39.59% | $19.42M | |
| -107.89% | $0 |
Build a custom stock screener for ZIVO Bioscience, Inc. (ZIVO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ZIVO Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
ZIVO Bioscience, Inc. (ZIVO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like ZIVO Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is ZIVO Bioscience, Inc.'s ROE?
How is the ROE calculated for ZIVO Bioscience, Inc. (ZIVO)?
What is the highest ROE for ZIVO Bioscience, Inc. (ZIVO)?
What is the 3-year average ROE for ZIVO Bioscience, Inc. (ZIVO)?
What is the 5-year average ROE for ZIVO Bioscience, Inc. (ZIVO)?
How does the current ROE for ZIVO Bioscience, Inc. (ZIVO) compare to its historical average?